Skip to main content

Month: September 2025

Silynxcom Announces First Half of 2025 Financial Results, Expands Client Diversity and Raised $2.9M to Support Growth

Netanya, Israel, Sept. 26, 2025 (GLOBE NEWSWIRE) — Silynxcom Ltd. (NYSE American: SYNX) (“Silynxcom” or the “Company”), a manufacturer and developer of ruggedized tactical communication headset devices, has released its consolidated financial results as of and for the six months ended June 30, 2025. The Company highlighted significant progress in diversifying its client base across international markets, coupled with a strengthened financial position following a $2.9 million capital raise, positioning it for a future growth in the tactical communications sector. “We are kicking off a new phase of growth by strategically expanding our client base across the U.S., Europe, and Asia, while leveraging new orders and innovative products to meet rising global defense needs,” said Nir Klein, Chief Executive Officer of Silynxcom. “With...

Continue reading

Coherent Unveils Next-Generation Multi-Rail Technology With Breakthrough Performance for Optical Transport

Coherent Multi-Rail technology platformCoherent unveils next-generation Multi-Rail technology with breakthrough performance for optical transportSAXONBURG, Pa., Sept. 26, 2025 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), a global leader in photonics, today announced major upgrades to its Multi-Rail technology platform, delivering greater efficiency, scale, and speed for the next era of optical transport networks. At the heart of the platform is a new Dynamic Gain Equalizer (DGE) that combines C and L bands in a single compact module. This unique product doubles the transmission bandwidth while cutting footprint by 20%, enabling hyperscale operators to grow capacity without adding equivalent racks, power, or cooling. Coherent also advanced its Optical Channel Monitoring (OCM), reducing scan times by half and supporting...

Continue reading

Drugs Made In America Acquisition II Corp. Announces Closing of $500,000,000 Initial Public Offering

Fort Lauderdale, FL, Sept. 26, 2025 (GLOBE NEWSWIRE) — Drugs Made In America Acquisition II Corp. (Nasdaq: DMIIU) (the “Company”) today announced that it closed its initial public offering of 50,000,000 units at $10.00 per unit. The gross proceeds from the offering were $500 million before deducting underwriting discounts and offering expenses. The units began trading on The Nasdaq Global Market (“Nasdaq“) under the ticker symbol “DMIIU” on September 25, 2025. Each unit consists of one ordinary share and one right to receive one-tenth (1/10) of an ordinary share upon the consummation of an initial business combination. Once the securities comprising the units begin separate trading, the ordinary shares and rights are expected to be listed on Nasdaq under the symbols “DMII” and “DMIIR,”...

Continue reading

Palisade Bio Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum

Carlsbad, CA, Sept. 26, 2025 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that the Company’s special meeting of stockholders held on September 26, 2025 at 10:00 a.m. Pacific Time was convened and adjourned, without any business being conducted, due to lack of the required quorum. A quorum consists of one-third of the outstanding shares of the Company’s common stock entitled to vote at the special meeting. There were fewer than one-third of outstanding shares of the Company’s common stock entitled to vote present, either in person or by proxy at this meeting. The special meeting of stockholders therefore had no quorum...

Continue reading

Oculis Publishes Notification of Transactions by Person Discharging Managerial Responsibilities

ZUG, Switzerland, Sept. 26, 2025 (GLOBE NEWSWIRE) — The attached notification relates to trades entered into by a PDMR of the Company pursuant to a 10b5-1 trading plan, in accordance with Rule 10b5-1(c)(1) of the Securities Exchange Act of 1934, as amended.Attachmentpdmr-notification-r-sherif-sales-sep 2025

Continue reading

Maris-Tech Announces Financial Results for the Six Months Ended June 30, 2025

The company continues to advance AI-powered video streaming and edge computing solutions for the defense and HLS markets Rehovot, Israel , Sept. 26, 2025 (GLOBE NEWSWIRE) — Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the “Company”), a global leader in video and artificial intelligence (“AI”) – based edge computing technology, today announced its financial results for the six months ended June 30, 2025. Revenues for the six-months ended June 30, 2025, were $707,021, compared to $3,410,258 for the same six-month period in 2024. Net loss for the six-months ended June 30, 2025, was $2,388,294, compared to net income of $131,797 for the same six-month period in 2024. Total cash and cash equivalents as of June 30, 2025 were $2,769,901, compared to $2,294,679 as of June 30, 2024. Israel Bar, Chief Executive Officer of Maris-Tech,...

Continue reading

Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025

NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today announced that it will host a conference call and live webcast at 8:30 am ET on September 29, 2025, to discuss recently announced updated overall survival and safety data in first-line pancreatic cancer patients treated with atebimetinib + mGnP (N=34) with 9 months median follow up. “These exciting results were first announced in our press release on September 24, 2025, will be highlighted in a poster presentation at the Pancreatic Cancer Action Network (PanCAN) Scientific Summit 2025 on Sunday, and will be discussed during our conference call on Monday. We are committed to ensuring the community has multiple opportunities to engage with and understand these important...

Continue reading

Scilex Holding Company Announces Closing of Previously Announced Initial Tranche Investment in Datavault AI

PALO ALTO, Calif. , Sept. 26, 2025 (GLOBE NEWSWIRE) — Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that it has closed the initial tranche of its previously announced $150 million Bitcoin (BTC) investment in Datavault AI Inc. (Nasdaq: DVLT, “Datavault”), pursuant to which Scilex is expected to receive up to an aggregate of 278,914,094 shares of Datavault common stock (at an effective purchase price of $0.5378 per share) (subject to adjustment for stock splits and similar transactions). At the closing of this initial tranche, Scilex received 15,000,000 shares of Datavault...

Continue reading

Yunhong Green CTI Ltd. Announces Execution of Reverse Stock Split

Company Stock Will Begin Trading on Split Adjusted Basis October 1, 2025 LAKE BARRINGTON, IL, Sept. 26, 2025 (GLOBE NEWSWIRE) — Yunhong Green CTI Ltd. (Nasdaq: YHGJ) (“Yunhong Green CTI” or the “Company”), a leading manufacturer of custom film products, foil novelty balloons, and flexible packaging products, today announced that it will proceed with a 1-for-10 reverse stock split of its shares of common stock (the “Reverse Stock Split”) following approval by its Board of Directors. The Reverse Stock Split was approved by the Company’s stockholders at the annual meeting of stockholders held on August 22, 2025. The Reverse Stock Split is expected to be effective on October 1, 2025 (the “Effective Time”). The Company’s common stock is expected to begin trading on a split-adjusted basis...

Continue reading

Sunrise New Energy Announces 1GW U.S. Lithium Battery Pack Project Driving Growth in Anode Material Sales

ZIBO, China, Sept. 26, 2025 (GLOBE NEWSWIRE) — Sunrise New Energy Co., Ltd. (“Sunrise”, the “Company”, “we” or “our”) (NASDAQ: EPOW), a leading manufacturer and innovator of battery anode materials, today announced that it will build a 1GW lithium battery pack project in the United States through its newly established U.S. subsidiary, Alchemistica Incorporated. This strategic initiative is designed to capture the rapidly expanding market demand for energy storage batteries in the United States and North America, including residential and commercial & industrial (C&I) applications. The project will leverage the expertise of Mr. Haiping Hu, the founder and CEO of Sunrise, who is a highly experienced expert in the energy storage industry. Mr. Hu has led an international team for many years in battery pack production, technology...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.